Weiyan Lai

507 total citations
15 papers, 389 citations indexed

About

Weiyan Lai is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Weiyan Lai has authored 15 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Weiyan Lai's work include Chronic Kidney Disease and Diabetes (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and Renal and related cancers (2 papers). Weiyan Lai is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and Renal and related cancers (2 papers). Weiyan Lai collaborates with scholars based in China, United States and Hong Kong. Weiyan Lai's co-authors include Tanqi Lou, Yin Li, Hui Peng, Zengchun Ye, Ming Li, Canming Li, Jiayan Huang, Xiaohao Zhang, Ziying Yao and Xiao Ru Huang and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Kidney International.

In The Last Decade

Weiyan Lai

15 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiyan Lai China 9 139 113 79 70 64 15 389
Dingping Yang China 17 196 1.4× 229 2.0× 88 1.1× 49 0.7× 70 1.1× 29 538
Xueyan Yang China 10 169 1.2× 131 1.2× 71 0.9× 30 0.4× 40 0.6× 18 380
Keun Suk Yang South Korea 8 181 1.3× 114 1.0× 101 1.3× 28 0.4× 103 1.6× 9 472
Muhammed M. Yaqoob United Kingdom 10 184 1.3× 94 0.8× 95 1.2× 20 0.3× 51 0.8× 15 483
Jiarong Xu China 8 157 1.1× 48 0.4× 142 1.8× 24 0.3× 66 1.0× 12 425
Jin He China 8 151 1.1× 41 0.4× 42 0.5× 35 0.5× 33 0.5× 18 327
Nan Mao China 11 128 0.9× 78 0.7× 67 0.8× 31 0.4× 13 0.2× 33 289
Qunzi Zhang China 12 135 1.0× 196 1.7× 58 0.7× 34 0.5× 12 0.2× 20 488
Jiamei Lu China 13 264 1.9× 55 0.5× 88 1.1× 20 0.3× 48 0.8× 24 542

Countries citing papers authored by Weiyan Lai

Since Specialization
Citations

This map shows the geographic impact of Weiyan Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyan Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyan Lai more than expected).

Fields of papers citing papers by Weiyan Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyan Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyan Lai. The network helps show where Weiyan Lai may publish in the future.

Co-authorship network of co-authors of Weiyan Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyan Lai. A scholar is included among the top collaborators of Weiyan Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyan Lai. Weiyan Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhou, Bin, et al.. (2025). Prognostic implications of system inflammation response index in atrial fibrillation patients with type 2 diabetes mellitus. Scientific Reports. 15(1). 1025–1025. 6 indexed citations
2.
He, Yu, Jiawen Li, Weiyan Lai, et al.. (2025). Joint effects of sodium intake and circadian rhythm of urinary sodium excretion on prognosis of chronic kidney disease: a prospective study. Therapeutic Advances in Chronic Disease. 16. 404393050–404393050. 1 indexed citations
3.
Peng, Long, Yuxiang Sun, Juan Sun, et al.. (2025). Irisin‐mediated muscle‐renal crosstalk as a protective mechanism against contrast‐induced acute kidney injury via cGAS‐STING signalling inhibition. Clinical and Translational Medicine. 15(3). e70235–e70235. 3 indexed citations
4.
Yang, Chen, Shaomin Li, Ke Yang, et al.. (2024). Triglyceride–Glucose Index and Prognosis in Individuals Afflicted with Heart Failure and Chronic Kidney Disease. ESC Heart Failure. 11(5). 3120–3132. 10 indexed citations
5.
Li, Shaomin, et al.. (2024). Impact of lactate/albumin ratio on prognostic outcomes in patients with concomitant heart failure and chronic kidney disease. Internal and Emergency Medicine. 19(6). 1625–1636. 8 indexed citations
6.
Huang, Jiayan, Jian Ye, Yi Gao, et al.. (2024). Identification of proteins related to SIS3 by iTRAQ and PRM-based comparative proteomic analysis in cisplatin-induced acute kidney injury. PeerJ. 12. e17485–e17485. 1 indexed citations
7.
Wu, Lingzhi, Hongchun Lin, Shaomin Li, et al.. (2024). Macrophage iron dyshomeostasis promotes aging‐related renal fibrosis. Aging Cell. 23(11). e14275–e14275. 23 indexed citations
8.
Lai, Weiyan, Yin Li, Qianqian Wang, et al.. (2023). Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes. The FASEB Journal. 37(10). e23175–e23175. 19 indexed citations
9.
Huang, Jiayan, Weiyan Lai, Ming Li, et al.. (2022). SIS3 Alleviates Cisplatin-Induced Acute Kidney Injury by Regulating the LncRNA Arid2-IR-Transferrin Receptor Pathway. Kidney & Blood Pressure Research. 47(12). 729–741. 8 indexed citations
10.
Li, Yuanqing, Hongchun Lin, Yuxiang Sun, et al.. (2022). Integrative transcriptome analysis reveals TEKT2 and PIAS2 involvement in diabetic nephropathy. The FASEB Journal. 36(11). e22592–e22592. 7 indexed citations
11.
Lin, Hongchun, et al.. (2022). Integrative Transcriptome Analysis Reveals TEKT2 and PIAS2 Involvement in Diabetic Nephropathy. Journal of the American Society of Nephrology. 33(11S). 665–666. 1 indexed citations
12.
Li, Ming, Canming Li, Jiayan Huang, et al.. (2020). Sirt3 modulates fatty acid oxidation and attenuates cisplatin‐induced AKI in mice. Journal of Cellular and Molecular Medicine. 24(9). 5109–5121. 104 indexed citations
13.
Li, Yin, Zengchun Ye, Weiyan Lai, et al.. (2017). Activation of Sirtuin 3 by Silybin Attenuates Mitochondrial Dysfunction in Cisplatin-induced Acute Kidney Injury. Frontiers in Pharmacology. 8. 178–178. 93 indexed citations
14.
Ye, Zengchun, Cheng Wang, Hui Peng, et al.. (2017). The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells. Scientific Reports. 7(1). 39727–39727. 45 indexed citations
15.
Lai, Weiyan, Ying Tang, Xiao Ru Huang, et al.. (2016). C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin E. Kidney International. 90(3). 610–626. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026